Disease burden and health-related quality of life among adults aged 50 years or older with herpes zoster in Huzhou, China.

Authors

Shangyan Han, Jie Gong, Jianyong Shen, Xiaofu Luo, Zizhe Zhang, Xiaoqi Liu, Yu Hu

Published in

Frontiers in public health. Volume 14. Pages 1929296. Epub Sep 09, 2026.

Abstract

This study assessed the disease burden and health-related quality of life (HRQoL) among adults aged 50 years and older with herpes zoster (HZ) in Huzhou, China, and identified factors associated with increased disease burden.
A cross-sectional study was conducted among adults aged 50 years or older who developed HZ between 1 June 2024 and 1 June 2025 in Huzhou, China. Participants completed a structured questionnaire in September 2025 after the acute phase and retrospectively reported HRQoL during the acute HZ phase; participants with PHN also reported HRQoL during the PHN phase. Disease-burden and HRQoL distributions were compared using the Mann-Whitney U test or Kruskal-Wallis test, as appropriate. Gamma generalized linear models (GLMs) with a log link were used to identify factors associated with total, direct, and indirect burden.
A total of 222 participants were included, of whom 62 (27.9%) developed PHN. Costs were recorded in RMB as gross disease-related expenditures before reimbursement and converted using USD = RMB/7.1. The median direct burden was RMB 39,998.58 (P25, P75: RMB 11,792.27, 277,962.43), equivalent to USD 5,633.62 (P25, P75: USD 1,660.88, 39,149.64), and the median indirect burden was RMB 1,843.59 (USD 259.66; P25, P75: USD 155.79, 519.31). Participants with PHN had a higher median total burden than those without PHN (USD 10,958.43 vs. USD 4,740.60; p < 0.001). During the acute HZ phase, the median EQ-5D-5L utility and EQ-VAS scores were 0.40 (P25, P75: -0.03, 0.53) and 10.00 (P25, P75: 10.00, 10.00), respectively. Treatment setting, PHN status, and age were associated with disease burden.
Herpes zoster was associated with substantial disease burden and markedly impaired HRQoL among adults aged 50 years or older in Huzhou. PHN and inpatient treatment identified subgroups with particularly high burden. These regional estimates may inform prevention policy and future evaluations of HZ vaccination.

PMID:
42819195
Bibliographic data and abstract were imported from PubMed on 02 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.